JP Morgan Chase & Co’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.75M | Sell |
|
|||||
|
2025
Q2 | $2.69M | Sell |
|
|||||
|
2025
Q1 | $2.46M | Sell |
|
|||||
|
2024
Q4 | $4.01M | Sell |
|
|||||
|
2024
Q3 | $5.96M | Sell |
|
|||||
|
2024
Q2 | $6.62M | Sell |
|
|||||
|
2024
Q1 | $10.7M | Sell |
|
|||||
|
2023
Q4 | $10.2M | Sell |
|
|||||
|
2023
Q3 | $8.37M | Sell |
|
|||||
|
2023
Q2 | $9.71M | Sell |
|
|||||
|
2023
Q1 | $8.19M | Sell |
|
|||||
|
2022
Q4 | $5.82M | Sell |
|
|||||
|
2022
Q3 | $5.13M | Buy |
|
|||||
|
2022
Q2 | $5.12M | Sell |
|
|||||
|
2022
Q1 | $8.77M | Sell |
|
|||||
|
2021
Q4 | $13.1M | Buy |
|
|||||
|
2021
Q3 | $11.2M | Sell |
|
|||||
|
2021
Q2 | $8.99M | Buy |
|
|||||
|
2021
Q1 | $10M | Buy |
|
|||||
|
2020
Q4 | $5.16M | Buy |
|
|||||
|
2020
Q3 | $1.86M | Buy |
|
|||||
|
2020
Q2 | $1.6M | Buy |
|
|||||
|
2020
Q1 | $288K | Sell |
|
|||||
|
2019
Q4 | $698K | Buy |
|
|||||
|
2019
Q3 | $476K | Buy |
|
|||||
|
2019
Q2 | $128K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $148K | Buy |
|
|||||
|
2018
Q2 | $74K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $95K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $6K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $10K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $9.44M | Sell |
|
|||||
|
2014
Q2 | $14.3M | Buy |
|
|||||
|
2014
Q1 | $14.7M | Buy |
|
|||||
|
2013
Q4 | $10.8M | Buy |
|
|||||
|
2013
Q3 | $5.38M | Buy |
|
|||||
|
2013
Q2 | $1.64M | Buy |
|